Three Studies Reveal New Insights into Osteoporosis and Bone Health A trio of studies from the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism examines several issues relating to bone health complications. These papers looked at treatment options to increase bone density in breast cancer patients; the impact of sleeve gastrectomy procedures on bone mass...
Marrow Fat Not a Reliable Marker for Fragility Fracture Risk in Postmenopausal Women
A new study has found that bone marrow fat content, as measured by advanced imaging techniques, does not predict the risk of fractures in postmenopausal women. The findings, recently published in The Journal of the Endocrine Society, challenge the idea that bone marrow adipose tissue (BMAT) plays a significant role in fracture susceptibility and suggest...
A Game-Changer in Osteoporosis and Fracture Prevention On behalf of Endocrine Society’s Bone and Mineral Special Interest Group Steering Committee, Vafa Tabatabaie, MD, and Muriel Babey, MD, discuss the importance of fracture liaison services, how they can contribute to an improved quality of life for the patients as well as cost savings for the facility,...
High Time: Addressing Research Gaps in Opioid-Associated Endocrine Conditions
Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare...
Endocrine Society Scientific Statement Reviews Research on Opioids’ Effect on Bone, Adrenal Health
A new Scientific Statement released by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system. The use and misuse of opioids are a growing global problem. Opioids are used to treat pain in people with cancer or other conditions (e.g., after an injury or surgery), however,...
Good Vibrations: A New FDA-Approved Device Could Offer a Solution for Osteopenia Treatment
In a first for the treatment of osteopenia, the Osteoboost — a wearable device that delivers precise vibrations to the spine and hips — promises to offer a new form of therapy for clinicians treating postmenopausal women dealing with a loss of bone density. At the beginning of 2024, the U.S. Food and Drug...
The Joy of Endocrinology: Joy Y. Wu, MD, PhD, Breaks the Glass and Bamboo Ceilings
As Endocrine News celebrates Asian American and Pacific Islander Heritage Month, we talk to Joy Y. Wu, MD, PhD, chief of the Division of Endocrinology at Stanford University about her personal and professional journey through the field of endocrinology as well as how her career path has been shaped by her mentors, colleagues, and especially...Getting Back to Normal: Options for Treating Hypoparathyroidism
Endocrine News talks to Aliya Khan, MD, about the debilitating effects of hypoparathyroidism, new treatment guidelines she helped create, and exciting news from trials that showed promising results that could allow these patients to have a much-improved quality of life, both physical and psychological. “I wish I had this medicine when I was a kid,”...
